{"id":6695,"date":"2024-11-21T16:01:25","date_gmt":"2024-11-21T15:01:25","guid":{"rendered":"https:\/\/beigen.vipdev.lndo.site\/us\/?post_type=publication&p=6695"},"modified":"2025-04-28T22:16:33","modified_gmt":"2025-04-28T20:16:33","slug":"safety-and-efficacy-of-zanubrutinib-in-relapsed-refractory-marginal-zone-lymphoma-final-analysis-of-the-magnolia-study","status":"publish","type":"publication","link":"https:\/\/beonemedaffairs.com\/us\/publication\/safety-and-efficacy-of-zanubrutinib-in-relapsed-refractory-marginal-zone-lymphoma-final-analysis-of-the-magnolia-study\/","title":{"rendered":"Safety and efficacy of zanubrutinib in relapsed\/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study"},"content":{"rendered":"","protected":false},"template":"","post-tag":[],"class_list":["post-6695","publication","type-publication","status-publish","hentry","disease_state-marginal-zone-lymphoma","molecule-zanubrutinib"],"acf":[],"_links":{"self":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/publication\/6695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/media?parent=6695"}],"wp:term":[{"taxonomy":"post-tag","embeddable":true,"href":"https:\/\/beonemedaffairs.com\/us\/wp-json\/wp\/v2\/post-tag?post=6695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}